Janssen seeks EU approval for first CAR-T therapy cilta-cel

4th May 2021 Uncategorised 0

Cilta-cel is an investigational CAR-T cell therapy for the treatment of relapsed/refractory multiple myeloma

More: Janssen seeks EU approval for first CAR-T therapy cilta-cel
Source: News